Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13177803 | 0.91 | CARM1 (0.48) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL10702555 | 0.90 | ALDH1A1 (0.50) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL10702177 | 0.88 | PDIA6 (0.56) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL10870432 | 0.88 | PDIA6 (0.51) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL10870020 | 0.86 | PDIA6 (0.54) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL11650358 | 0.86 | PDIA6 (0.54) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL26023458 | 0.85 | NPC1 (0.48) | CARM1PDIA6NPC1MAPTHTT | |
| SCHEMBL11444520 | 0.85 | SKP2 (0.55) | PDIA6NPC1MAPTHTTRAB9A | |
| SCHEMBL10187313 | 0.85 | MAPT (0.53) | PDIA6NPC1MAPTHTTRAB9A | |
| SCHEMBL8091595 | 0.84 | DRD2 (0.51) | CARM1TAAR1PDIA6NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1674075-B1 | Hair colouring process comprising a cleaning step | ORÉAL L (FR) | 2016-07-20 | — | — | EP | claimed |
| US-7485155-B2 | Process for washing colored keratinous fibers with a composition comprising at least one nonionic surfactant and method for protecting the color | L'OREAL S.A. (FR) | 2009-02-03 | — | — | US | claimed |
| US-20060156478-A1 | Process for washing colored keratinous fibers with a composition comprising at least one nonionic surfactant and method for protecting the color | L'OREAL S.A. (FR) | 2006-07-20 | — | — | US | claimed |
| EP-1674075-A1 | Colored hair treating process with a composition comprising a specific non ionic surfactant and use to protect the coloration | L'OREAL (FR) | 2006-06-28 | — | — | EP | claimed |
| EP-1674074-A1 | Colored hair treating process with a composition comprising a specific non ionic and/or an amphoteric and/or a mild anionic surfactant and use to protect the coloration | L'OREAL (FR) | 2006-06-28 | — | — | EP | claimed |
| WO-2020140055-A1 | CYCLIN-DEPENDENT KINASE INHIBITORS | SPV THERAPEUTICS INC. (US) | 2020-07-02 | — | — | WO | disclosed |
| WO-2020140052-A1 | CYCLIN-DEPENDENT KINASE INHIBITORS | SPV THERAPEUTICS INC. (US) | 2020-07-02 | — | — | WO | disclosed |
| EP-1674075-B1 | Hair colouring process comprising a cleaning step | ORÉAL L (FR) | 2016-07-20 | — | — | EP | disclosed |
| US-7485155-B2 | Process for washing colored keratinous fibers with a composition comprising at least one nonionic surfactant and method for protecting the color | L'OREAL S.A. (FR) | 2009-02-03 | — | — | US | disclosed |
| US-20060156478-A1 | Process for washing colored keratinous fibers with a composition comprising at least one nonionic surfactant and method for protecting the color | L'OREAL S.A. (FR) | 2006-07-20 | — | — | US | disclosed |
| EP-1674075-A1 | Colored hair treating process with a composition comprising a specific non ionic surfactant and use to protect the coloration | L'OREAL (FR) | 2006-06-28 | — | — | EP | disclosed |
| US-5932582-A | Fibrinogen receptor antagonist prodrugs | MERCK & CO., INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0912513-A1 | FIBRINOGEN RECEPTOR ANTAGONIST PRODRUGS | Merck & Co., Inc. (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998000401-A1 | FIBRINOGEN RECEPTOR ANTAGONIST PRODRUGS | MERCK & CO., INC. (US) | 1998-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060156478-A1 | Process for washing colored keratinous fibers with a composition comprising at least one nonionic surfactant and method for protecting the color | KRT18, DSG1, DSP | CARM1 2196/4885TAAR1 2358/4885PDIA6 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.